European Journal of Applied Physiology

, Volume 98, Issue 5, pp 472–481 | Cite as

The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome

  • Susanne Ring-Dimitriou
  • Bernhard Paulweber
  • Serge P. von DuvillardEmail author
  • Monika Stadlmann
  • Linda M. LeMura
  • Josef Lang
  • Erich Müller
Original Article


The purpose of this study was to measure changes in plasma adiponectin (ApN) over 24 months of exercise intervention in middle age adults with a predisposition to metabolic syndrome and to determine if changes in ApN were more affected by physical activity or physical fitness. Thirty-six subjects completed a 24 months home-based exercise program (cycling ≥ three times per week, ≥ 45 min/session at 50–65% of VO2peak). Body composition, blood samples, and physical fitness were studied at baseline and after 12 and 24 months of participation in the study. The prescribed physical activity was monitored via self-reported exercise diary to determine MET levels, hours, and exercise compliance. Two-tailed repeated measures ANOVA and Spearman Rank Correlation Coefficients were used to detect significant differences and associations between the variables. ApN increased significantly (P < 0.05) after 12 months in males (n = 17; 5.3 ± 1.9–7.0 ± 3.0 μg ml−1) but not in females (n = 9; 8.6 ± 3.8–11.5 ± 4.0 μg ml−1). The net change in ApN over 24 months was significantly correlated to the net change in VO2peak (physical fitness) (r = 0.66; P < 0.001), whereas exercise intensity was negatively correlated to ΔApN over 12 months (r = −0.4; P ≤ 0.04) and 24 months (r = −0.45; P ≤ 0.02). Based on our results, an improvement in cardiorespiratory fitness of 15% increased plasma ApN concentration. Our findings suggest that moderate physical activity performed over many months induces positive changes in the plasma ApN concentration in adults with a predisposition to metabolic syndrome.


Aerobic fitness Exercise Adiponectin Metabolic syndrome 


  1. Borghouts LB, Backx K, Mensink MF, Keizer HA (1999) Effect of training intensity on insulin sensitivity as evaluated by insulin tolerance test. Eur J Appl Physiol 80:461–466CrossRefGoogle Scholar
  2. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier J-F (2003) Absence of exercise—induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 149(5): 421–424PubMedCrossRefGoogle Scholar
  3. Buemann B, Sorensen TIA, Pedersen O, Black E, Holst C, Toubro s, Echwald S, Holst JJ, Rasmussen C, Astup A (2005) Lower-body fat mass as an independent marker of insulin sensitivity—the role of adiponectin. Int J Obesity 29:624–631CrossRefGoogle Scholar
  4. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob JJ, Black AE, Maas D, Tahashi M, Kihara s, tanaka s, Matsuzawa Y, Blangero J, Cohen D, Kissebah A (2001) The genetic basis of plasma variation in adiponectin, a global endophenotypoe for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86(9):4321–4325PubMedCrossRefGoogle Scholar
  5. Eriksson J, Lindström J, Valle T, Aunola S, Hämälainen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S., Laakso M, Lauhkonen M., Lehto P, Lehtonen A, Louheranta A, Mannelin M., Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J (1999) Prevention of type II diabetes in subjects with impaired glucose tolerance: the diabetes prevention study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793–801PubMedCrossRefGoogle Scholar
  6. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289(14):1799–1804PubMedCrossRefGoogle Scholar
  7. Ferguson MA, White LJ, McCoy S, Kim H-W, Petty T, Wilsey J (2004) Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 91:324–329PubMedCrossRefGoogle Scholar
  8. Haque WA, Shimomura I, Matsuzawa Y, Garg A (2002) Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87(5):2395–2398PubMedCrossRefGoogle Scholar
  9. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, Okazaki Y, Ishii T, Oguma Y, Takei I, Saruta T (2002). Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51(3):341–347CrossRefGoogle Scholar
  10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Murguchi M, Ohmoto Y, Nakmura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595–1599PubMedGoogle Scholar
  11. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, Macdonald KG, Dohm GL (2002) Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283:E861–E865PubMedGoogle Scholar
  12. IDF consensus worldwide definition of the metabolic syndrome (2005). Cited 14 April 2005
  13. Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A (2003) Effect of exercise on total and intra-abdominal body fat in postmenopausal women. JAMA 289(3):323–330PubMedCrossRefGoogle Scholar
  14. Jurimae J, Purge P, Jurimae T (2005) Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 93(4):502–505PubMedCrossRefGoogle Scholar
  15. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y (2001) Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24(2):362–365PubMedGoogle Scholar
  16. Kraemer RR, Aboudehen KS, Carruth AK, Durand RJ, Acevedo EO, Hebert EP, Johnson LG, Daniel CV (2003) Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc 35(8):1320–1325PubMedCrossRefGoogle Scholar
  17. Kriketos AD, Gan SK, Poyneten AM, Furler SM, Chisholm DJ, Campbell LV (2004) Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27(2):629–630PubMedGoogle Scholar
  18. Lean MEJ, Han TS, Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. Br Med J 311:158–161Google Scholar
  19. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD (2005) Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metab Clin Exp 54:533–541PubMedGoogle Scholar
  20. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzros CS (2003) Effect of lifestyle modification on adipokine levels in obese subject with insulin resistance. Obes Res 11:1048–1054PubMedCrossRefGoogle Scholar
  21. NCEP (National cholesterol Education Program) ATP III (Adult Treatment Panel III) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497Google Scholar
  22. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291(14):1730–1737PubMedCrossRefGoogle Scholar
  23. Punyadeera C, Zorenc AHG, Koopman R, McAinch AJ, Smit E, Manders R, Keizer HA, Cameron-Smith D, van Loon LJC (2005) Clinical Study: the effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 153(3):427–436CrossRefGoogle Scholar
  24. Qi L, Rimm E, Liu S, Rifai N, Hu FB (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28(5):1022–1028PubMedGoogle Scholar
  25. Ring S, Paulweber B, Weiss M, Mueller E (2003) Long-term effects of an exercise intervention on physical fitness and apolipoproteins in people with metabolic syndrome. In: Jeschke D and Lorenz R (eds) Sportmedizinische trainingssteuerung. Sport-Prävention-Therapie Köln: Sport und Buch Strauß 339–348Google Scholar
  26. Ross R, Freeman J, Janssen I (2000) Exercise alone is an effective strategy for reducing obesity and related comorbidities. Exerc Sport Sci Rev 28(4):165–170PubMedGoogle Scholar
  27. Ryan AS, Nicklas BJ, Berman DM, Elahi D (2003a) Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postemopausal women. Int J Obes 27(9):1066–1071CrossRefGoogle Scholar
  28. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerlich RL, Meneilly GS, Egan JM, Elahi D (2003b) Plasma adiponectin an leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26(8):2383–2388Google Scholar
  29. Tsukinoki R, Morimoto K, Nakayama K (2005) Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 4:27–34PubMedCrossRefGoogle Scholar
  30. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S., Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350PubMedCrossRefGoogle Scholar
  31. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe St, Staiger H, Maerker E, Häring H, Stumvoll M (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239–243PubMedGoogle Scholar
  32. Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyörälä K (1998) Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Task Force Report. Eur Heart J 19:1434–1503CrossRefGoogle Scholar
  33. Yatagai T, Nishida Y, Nagasaka S, Nakamura T, Tokuyama K, Shindo M, Tanaka H, Ishibashi S (2003) Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 50(2):233–238PubMedCrossRefGoogle Scholar
  34. Yokoyama H, Hirose H, Ohgo H, Saito I (2004a) Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 43(6):453–457CrossRefGoogle Scholar
  35. Yokoyama H, Emoto M, Araki T, Fujiwara S, Motoyama K, Morioka T, Koyama H, Shoji T, Okuno Y, Nishizawa Y (2004b) Effect of aerobic exercise on plasma adiponectin leveles and insulin resistance in type 2 diabetes. Diabetes Care 27(7):1756–1758Google Scholar
  36. Zietz H, Herfarth H, Paul G, Ehling A, Müller-Ladner U, Schölmerich J, Schäffler A (2003) Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 545:103–104PubMedCrossRefGoogle Scholar
  37. WHO (1998) Obesity. Preventing and managing the global epidemic. World Health Organization, GenevaGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Susanne Ring-Dimitriou
    • 1
  • Bernhard Paulweber
    • 2
  • Serge P. von Duvillard
    • 3
    Email author
  • Monika Stadlmann
    • 1
  • Linda M. LeMura
    • 4
  • Josef Lang
    • 2
  • Erich Müller
    • 1
  1. 1.Department of Sport Science and KinesiologyUniversity of SalzburgSalzburgAustria
  2. 2.Department of Internal Medicine, St. Johanns HospitalPrivate Medical University of SalzburgSalzburgAustria
  3. 3.Human Performance Laboratory, Department of Health and Human PerformanceTexas A&M University-CommerceCommerceUSA
  4. 4.Department of BiologyLe Moyne CollegeSyracuseUSA

Personalised recommendations